Pharmaceutical company drives up patients' out-of-pocket costs for brain tumor drug to $1,000 PER PILL by removing it from Medicare rebate program
A key drug to fighting a rare form of brain cancer will be removed from Medicare soon, leaving many patients seeking thousands of dollars worth of costs to continue receiving treat…
